{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T01:13:25Z","timestamp":1772759605928,"version":"3.50.1"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008451","name":"Binghamton University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008451","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.neuint.2018.01.010","type":"journal-article","created":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T01:57:17Z","timestamp":1517882237000},"page":"85-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Striatal norepinephrine efflux in l-DOPA-induced dyskinesia"],"prefix":"10.1016","volume":"114","author":[{"given":"Corinne Y.","family":"Ostock","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nirmal","family":"Bhide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam A.","family":"Goldenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica A.","family":"George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4623-1085","authenticated-orcid":false,"given":"Christopher","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuint.2018.01.010_bib1","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/mds.1090","article-title":"Frequency of levodopa related dyskinesia and motor fluctuations as estimated from the cumulative literature","volume":"16","author":"Ahlskog","year":"2001","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuint.2018.01.010_bib2","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/syn.20535","article-title":"Reuptake of L-DOPA-derived extracellular DA in the striatum of a rodent model of Parkinson's disease via norepinephrine transporter","volume":"62","author":"Arai","year":"2008","journal-title":"Synapse"},{"key":"10.1016\/j.neuint.2018.01.010_bib3","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00702-005-0402-5","article-title":"Influence of noradrenaline denervation on MPTP-induced deficits in mice","volume":"113","author":"Archer","year":"2006","journal-title":"J.\u00a0Neural. Transm."},{"key":"10.1016\/j.neuint.2018.01.010_bib4","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.pbb.2011.09.009","article-title":"Effects of noradrenergic denervation on L-DOPA-induced dyskinesia and its treatment by\u202f??- And\u202f??-adrenergic receptor antagonists in hemiparkinsonian rats","volume":"100","author":"Barnum","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuint.2018.01.010_bib5","first-page":"222","article-title":"Effects of the beta-adrenergic receptor antagonist Propranolol on dyskinesia and L-DOPA-induced striatal DA efflux in the hemi-parkinsonian rat Nirmal","volume":"134","author":"Bhide","year":"2015"},{"key":"10.1016\/j.neuint.2018.01.010_bib6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","article-title":"Stages in the development of Parkinson's disease-related pathology","volume":"318","author":"Braak","year":"2004","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.neuint.2018.01.010_bib7","first-page":"589","article-title":"Sleep and circadian rhythm regulation in early Parkinson disease","volume":"71","author":"Breen","year":"2014","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.neuint.2018.01.010_bib8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/syn.20709","article-title":"The selective alpha1 adrenoceptor antagonist HEAT reduces L-DOPA-induced dyskinesia in a rat model of Parkinson's disease","volume":"64","author":"Buck","year":"2010","journal-title":"Synapse"},{"key":"10.1016\/j.neuint.2018.01.010_bib9","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neuroscience.2008.12.026","article-title":"Comparison of intrastriatal administration of noradrenaline and l-DOPA on dyskinetic movements: a bilateral reverse in\u00a0vivo microdialysis study in 6-hydroxydopamine-lesioned rats","volume":"159","author":"Buck","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2018.01.010_bib10","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1471-4159.2009.06482.x","article-title":"The alpha2 adrenoceptor antagonist idazoxan alleviates l-DOPA-induced dyskinesia by reduction of striatal dopamine levels: an in\u00a0vivo microdialysis study in 6-hydroxydopamine-lesioned rats","volume":"112","author":"Buck","year":"2010","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuint.2018.01.010_bib11","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1212\/WNL.46.6.1548","article-title":"Improvement of levodopa-induced dyskinesia by propranolol in Parkinson's disease","volume":"46","author":"Carpentier","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.neuint.2018.01.010_bib12","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1523\/JNEUROSCI.10-06-01847.1990","article-title":"Changes in striatal dopamine neurotransmission assessed with microdialysis following recovery from a bilateral 6-OHDA lesion: variation as a function of lesion size","volume":"10","author":"Castaneda","year":"1990","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuint.2018.01.010_bib13","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.tins.2007.03.005","article-title":"Dopamine dysregulation of movement control in l-DOPA-induced dyskinesia","volume":"30","author":"Cenci","year":"2007","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuint.2018.01.010_bib14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0079-6123(10)83011-0","article-title":"Maladaptive striatal plasticity in l-DOPA-induced dyskinesia","volume":"183","author":"Cenci","year":"2010","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuint.2018.01.010_bib15","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1046\/j.1460-9568.1998.00285.x","article-title":"L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA","volume":"10","author":"Cenci","year":"1998","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuint.2018.01.010_bib16","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1073\/pnas.68.3.662","article-title":"Effects of L-dopa on norepinephrine metabolism in the brain","volume":"68","author":"Chalmers","year":"1971","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.neuint.2018.01.010_bib17","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bbr.2007.01.013","article-title":"Modulation of l-DOPA-induced abnormal involuntary movements by clinically tested compounds: further validation of the rat dyskinesia model","volume":"179","author":"Dekundy","year":"2007","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuint.2018.01.010_bib18","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1136\/jnnp-2011-301817","article-title":"Dysfunction of the locus coeruleus-norepinephrine system and related circuitry in Parkinson's disease-related dementia","volume":"84","author":"Del Tredici","year":"2013","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuint.2018.01.010_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnsys.2011.00031","article-title":"Noradrenaline and Parkinson's disease","volume":"5","author":"Delaville","year":"2011","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.neuint.2018.01.010_bib20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2174\/157015906776359559","article-title":"On the origin of cortical dopamine: is it a Co-Transmitter in noradrenergic neurons?","volume":"4","author":"Devoto","year":"2006","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuint.2018.01.010_bib21","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1046\/j.1471-4159.2003.02239.x","article-title":"Alpha2-adrenoceptor mediated co-release of dopamine and noradrenaline from noradrenergic neurons in the cerebral cortex","volume":"88","author":"Devoto","year":"2004","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuint.2018.01.010_bib22","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00213-002-1381-y","article-title":"Co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex induced by clozapine, the prototype atypical antipsychotic","volume":"167","author":"Devoto","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuint.2018.01.010_bib23","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1006\/exnr.1996.6379","article-title":"Dopamine synthesis, uptake, metabolism, and receptors: relevance to gene therapy of Parkinson's disease","volume":"144","author":"Elsworth","year":"1997","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuint.2018.01.010_bib24","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1046\/j.1471-4159.1999.0720777.x","article-title":"Effects of pretreatment with N-(2-chloroethyl)-N-ethyl-2- bromobenzylamine (DSP-4) on methamphetamine pharmacokinetics and striatal dopamine losses","volume":"72","author":"Fornai","year":"1999","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuint.2018.01.010_bib25","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.brainres.2006.12.030","article-title":"Abnormal involuntary movements (AIMs) following pulsatile dopaminergic stimulation: severe deterioration and morphological correlates following the loss of locus coeruleus neurons","volume":"1135","author":"Fulceri","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2018.01.010_bib26","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/ana.410300308","article-title":"Alterations of dopaminergic and noradrenergic innervations in motor cortex in Parkinson's disease","volume":"30","author":"Gaspar","year":"1991","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2018.01.010_bib27","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1126\/science.2147780","article-title":"D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons","volume":"250","author":"Gerfen","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.neuint.2018.01.010_bib28","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0149-7634(00)00028-2","article-title":"The role of the locus coeruleus in the development of Parkinson's disease","volume":"24","author":"Gesi","year":"2000","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuint.2018.01.010_bib29","doi-asserted-by":"crossref","DOI":"10.1097\/00002826-199310000-00004","article-title":"Effect of nondopaminergic drugs on L-dopa-induced dyskinesias in MPTP-treated monkeys","author":"Gomez-Mancilla","year":"1993","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.neuint.2018.01.010_bib30","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/sleep\/29.10.1327","article-title":"Circadian regulation of arousal: role of the noradrenergic locus coeruleus system and light exposure","volume":"29","author":"Gonz\u00e1lez","year":"2006","journal-title":"Sleep"},{"key":"10.1016\/j.neuint.2018.01.010_bib31","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1586\/14737175.9.2.279","article-title":"Postural instability in Parkinson's disease: the adrenergic hypothesis and the locus coeruleus","volume":"9","author":"Grimbergen","year":"2009","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.neuint.2018.01.010_bib32","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0026-895X(25)12931-3","article-title":"Pharmacological characterization of rat alpha 2-adrenergic receptors","volume":"40","author":"Harrison","year":"1991","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuint.2018.01.010_bib33","first-page":"19","article-title":"Biochemical pathophysiology of Parkinson's disease","volume":"45","author":"Hornykiewicz","year":"1986","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.neuint.2018.01.010_bib34","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s002130050569","article-title":"A\u00a0partial noradrenergic lesion induced by DSP-4 increases extracellular noradrenaline concentration in rat frontal cortex: a microdialysis study in\u00a0vivo","volume":"136","author":"Hughes","year":"1998","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuint.2018.01.010_bib35","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1016\/S1353-8020(11)70038-4","article-title":"Striatal plasticity in Parkinson's disease and L-DOPA induced dyskinesia","volume":"18","author":"Iravani","year":"2012","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.neuint.2018.01.010_bib36","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.neuint.2006.08.004","article-title":"Norepinephrine acts as D1-dopaminergic agonist in the embryonic avian retina: late expression of beta1-adrenergic receptor shifts norepinephrine specificity in the adult tissue","volume":"50","author":"Kubrusly","year":"2007","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuint.2018.01.010_bib37","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1093\/brain\/awn085","article-title":"Sprouting of dopamine terminals and altered dopamine release and uptake in Parkinsonian dyskinaesia","volume":"131","author":"Lee","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.neuint.2018.01.010_bib38","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1124\/jpet.111.179416","article-title":"Behavioral and cellular modulation of L-DOPA-induced dyskinesia by beta-adrenoceptor blockade in the 6-hydroxydopamine-lesioned rat","volume":"337","author":"Lindenbach","year":"2011","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuint.2018.01.010_bib39","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/j.1471-4159.2009.06556.x","article-title":"L-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: temporal and quantitative relationship to the expression of dyskinesia","volume":"112","author":"Lindgren","year":"2010","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuint.2018.01.010_bib40","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0306-4522(91)90345-O","article-title":"Effects of locus coeruleus lesions on parkinsonian signs, striatal dopamine and substantia nigra cell loss after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in monkeys: a possible role for the locus coeruleus in the progression of Parkinson's disease","volume":"41","author":"Mavridis","year":"1991","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2018.01.010_bib41","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.brainres.2010.12.015","article-title":"Differential response of the central noradrenergic nervous system to the loss of locus coeruleus neurons in Parkinson's disease and Alzheimer's disease","volume":"1373","author":"McMillan","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2018.01.010_bib42","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.nbd.2006.01.009","article-title":"Increased slow oscillatory activity in substantia nigra pars reticulata triggers abnormal involuntary movements in the 6-OHDA-lesioned rat in the presence of excessive extracelullar striatal dopamine","volume":"22","author":"Meissner","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2018.01.010_bib43","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/j.1471-4159.2010.07137.x","article-title":"beta1-Adrenergic receptors activate two distinct signaling pathways in striatal neurons","volume":"116","author":"Meitzen","year":"2011","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuint.2018.01.010_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024679","article-title":"The locus coeruleus is directly implicated in l-Dopa-Induced dyskinesia in parkinsonian rats: an electrophysiological and behavioural study","volume":"6","author":"Miguelez","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2018.01.010_bib45","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1017\/S146114571000043X","article-title":"Locus coeruleus and dorsal raphe neuron activity and response to acute antidepressant administration in a rat model of Parkinson's disease","volume":"14","author":"Miguelez","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuint.2018.01.010_bib46","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1046\/j.1471-4159.1999.721516.x","article-title":"Role of high-affinity dopamine uptake and impulse activity in the appearance of extracellular dopamine in striatum after administration of exogenous L-DOPA: studies in intact and 6-hydroxydopamine-treated rats","volume":"72","author":"Miller","year":"1999","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuint.2018.01.010_bib47","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.nbd.2010.11.007","article-title":"Chronic L-DOPA therapy alters central serotonergic function and L-DOPA-induced dopamine release in a region-dependent manner in a rat model of Parkinson's disease","volume":"41","author":"Navailles","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2018.01.010_bib48","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0304-3940(91)90941-L","article-title":"Destruction of norepinephrine terminals in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice reduces locomotor activity induced by L-dopa","volume":"123","author":"Nishi","year":"1991","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuint.2018.01.010_bib49","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0026-895X(25)13494-9","article-title":"Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum","volume":"28","author":"Onali","year":"1985","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuint.2018.01.010_bib50","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.neuropharm.2015.03.008","article-title":"Modulation of L-DOPA\u2019s antiparkinsonian and dyskinetic effects by \u03b12-noradrenergic receptors within the locus coeruleus","volume":"95","author":"Ostock","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuint.2018.01.010_bib51","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bbr.2014.05.009","article-title":"Effects of noradrenergic denervation by anti-DBH-saporin on behavioral responsivity to l-DOPA in the hemi-parkinsonian rat","volume":"270","author":"Ostock","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuint.2018.01.010_bib52","first-page":"547612","volume":"vol. 170","author":"Paxinos","year":"2006"},{"key":"10.1016\/j.neuint.2018.01.010_bib53","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s00702-009-0291-0","article-title":"Effect of the additional noradrenergic neurodegeneration to 6-OHDA-lesioned rats in levodopa-induced dyskinesias and in cognitive disturbances","volume":"116","author":"P\u00e9rez","year":"2009","journal-title":"J.\u00a0Neural. Transm."},{"key":"10.1016\/j.neuint.2018.01.010_bib54","series-title":"Anti-dopamine Sympathectomy Immunotoxin-induced in Adult Rats1 1003\u20131010","author":"Picklo","year":"1995"},{"key":"10.1016\/j.neuint.2018.01.010_bib55","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0006-8993(94)90772-2","article-title":"Noradrenergic lesioning with an anti-dopamine beta-hydroxylase immuno","volume":"666","author":"Picklo","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2018.01.010_bib56","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/srep03730","article-title":"L-dopa-induced dyskinesia: beyond an excessive dopamine tone in the striatum","volume":"4","author":"Porras","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuint.2018.01.010_bib57","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1073\/pnas.81.5.1585","article-title":"Quantitative autoradiography of beta 1- and beta 2-adrenergic receptors in rat brain","volume":"81","author":"Rainbow","year":"1984","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.neuint.2018.01.010_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/0006-8993(74)90956-1","article-title":"Reserpine selectively increases tyrosine hydroxylase and dopamine-??-hydroxylase enzyme protein in central noradrenergic neurons","author":"Reis","year":"1974","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2018.01.010_bib59","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1037\/h0084241","article-title":"Compensatory changes in striatal dopamine neurons following recovery from injury induced by 6-OHDA or methamphetamine: a review of evidence from microdialysis studies","volume":"44","author":"Robinson","year":"1990","journal-title":"Can. J. Psychol."},{"key":"10.1016\/j.neuint.2018.01.010_bib60","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0006-8993(88)91560-0","article-title":"Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats","volume":"450","author":"Robinson","year":"1988","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2018.01.010_bib61","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bcp.2007.01.036","article-title":"Norepinephrine: the redheaded stepchild of Parkinson's disease","volume":"74","author":"Rommelfanger","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuint.2018.01.010_bib62","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1471-4159.2004.02785.x","article-title":"Reduced MPTP toxicity in noradrenaline transporter knockout mice","volume":"91","author":"Rommelfanger","year":"2004","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuint.2018.01.010_bib63","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1124\/mol.115.101808","article-title":"Evidence for noncanonical neurotransmitter activation: norepinephrine as a dopamine D2-like receptor agonist","volume":"89","author":"Sanchez-Soto","year":"2016","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuint.2018.01.010_bib64","doi-asserted-by":"crossref","DOI":"10.1111\/j.1742-4658.2008.06296.x","article-title":"Parkinson's disease: levodopa-induced dyskinesia and signal transduction","author":"Santini","year":"2008","journal-title":"FEBS J."},{"key":"10.1016\/j.neuint.2018.01.010_bib65","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.bbr.2004.03.002","article-title":"Treatment with \u03b12-adrenoceptor antagonist, 2-methoxy idazoxan, protects 6-hydroxydopamine-induced Parkinsonian symptoms in rats: neurochemical and behavioral evidence","volume":"154","author":"Srinivasan","year":"2004","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuint.2018.01.010_bib66","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1046\/j.1460-9568.2003.02684.x","article-title":"Potentiation of parkinsonian symptoms by depletion of locus coeruleus noradrenaline in 6-hydroxydopamine-induced partial degeneration of substantia nigra in rats","volume":"17","author":"Srinivasan","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuint.2018.01.010_bib67","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/00001756-199902250-00034","article-title":"Role of serotonergic neurons in L-DOPA-derived extracellular dopamine in the striatum of 6-OHDA-lesioned rats","volume":"10","author":"Tanaka","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuint.2018.01.010_bib68","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1002\/jnr.23439","article-title":"L-DOPA-induced dyskinesia in a rat model of Parkinson's disease is associated with the fluctuational release of norepinephrine in the sensorimotor striatum","volume":"92","author":"Wang","year":"2014","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuint.2018.01.010_bib69","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1471-4159.2007.05145.x","article-title":"Genetic or pharmacological blockade of noradrenaline synthesis enhances the neurochemical, behavioural, and neurotoxic effects of methamphetamine","volume":"105","author":"Weinshenker","year":"2008","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuint.2018.01.010_bib70","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0006-8993(96)00855-4","article-title":"Central noradrenergic lesioning using anti-DBH-saporin: anatomical findings","volume":"740","author":"Wrenn","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2018.01.010_bib71","article-title":"Altered resting-state functional connectivity of the striatum in Parkinson's disease after levodopa administration","volume":"11","author":"Yang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2018.01.010_bib72","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archneur.60.3.337","article-title":"Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in alzheimer and Parkinson diseases","volume":"60","author":"Zarow","year":"2003","journal-title":"Arch. Neurol."}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018617305260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018617305260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T21:38:34Z","timestamp":1751319514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018617305260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":72,"alternative-id":["S0197018617305260"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2018.01.010","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Striatal norepinephrine efflux in l-DOPA-induced dyskinesia","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2018.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}